- 全部删除
- 您的购物车当前为空
SB 271046 hydrochloride (SB 271046A) 是高效、选择性和具有口服活性的5-HT6受体拮抗剂,对大鼠、猪和人的pKi 分别为 9.02、8.55 和 8.81。它增加额叶皮层中的细胞外天冬氨酸和谷氨酸并表现出抗惊厥活性,EC50为 0.16 μM。它对 5-HT6 受体、结合位点和离子通道的选择性超过 200 倍。
为众多的药物研发团队赋能,
让新药发现更简单!
SB 271046 hydrochloride (SB 271046A) 是高效、选择性和具有口服活性的5-HT6受体拮抗剂,对大鼠、猪和人的pKi 分别为 9.02、8.55 和 8.81。它增加额叶皮层中的细胞外天冬氨酸和谷氨酸并表现出抗惊厥活性,EC50为 0.16 μM。它对 5-HT6 受体、结合位点和离子通道的选择性超过 200 倍。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 137 | In stock | |
2 mg | ¥ 191 | In stock | |
5 mg | ¥ 283 | In stock | |
10 mg | ¥ 479 | In stock | |
25 mg | ¥ 1,060 | In stock | |
50 mg | ¥ 1,990 | In stock | |
100 mg | ¥ 2,890 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 368 | In stock |
SB 271046 hydrochloride 相关产品
产品描述 | SB 271046 hydrochloride (SB 271046A) is selective, orally active 5-HT6 antagonist (pKi values are 9.02-8.92, 6.35, 6.55, 6.27 at 5-HT6, 5-HT1A, 5-HT1D and D3, and 6.05, 5.95, 5.76, 5.73, 5.62, 5.55, 5.41, 5.39, 5.27 and < 4.99 at 5-HT1B, 5-HT1F, α1B, 5-HT2C, 5-HT2A, D2, 5-HT2B, 5-HT7, 5-HT4 and 5-HT1E respectively) and is > 200-fold selective over 55 other receptors, enzymes and ion channels. It increases extracellular aspartate and glutamate in the frontal cortex and exhibits anticonvulsant activity (EC50: 0.16 μM). |
靶点活性 | 5-HT 7 Receptor:5.39 (pKi), 5-HT1E:<4.99 (pKi), 5-HT 1D Receptor:6.55 (pKi), 5-HT 1B Receptor:6.05 (pKi), 5-HT2C receptor (human):5.73 (pKi), 5-HT2B receptor:5.41 (pKi), 5-HT6:8.92(pKi), 5-HT 2A Receptor:5.62 (pKi), 5-HT4 receptor:5.27 (pKi), 5-HT 1A Receptor:6.35 (pKi), 5-HT1F receptor:5.95 (pKi) |
别名 | SB 271046A |
分子量 | 488.45 |
分子式 | C20H22ClN3O3S2·HCl |
CAS No. | 209481-24-3 |
Smiles | Cl.C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (92.13 mM), Sonication is recommended. ![]() | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容